期刊文献+

青蒿琥酯逆转裸鼠种植食管癌耐药作用研究 被引量:3

The resistance-reversal effect of artesunate on human esophageal cancer transplanted in nude mice
下载PDF
导出
摘要 目的探讨三磷酸腺苷结合转运蛋白G2(ABCG2)与食管癌多药耐药的关系以及青蒿琥酯(Art)逆转食管癌多药耐药的作用机制。方法将食管癌多药耐药细胞Eca109/ABCG2接种于裸鼠皮下,建立荷瘤裸鼠动物模型。裸鼠皮下成瘤后用药,经腹腔给予Art和(或)阿霉素(ADM),分为Art高、低剂量组(50、25mg/kg Art),ADM组(1mg/kg ADM)和ADM+Art高、低剂量组(1mg/kg ADM+50、25mg/kg Art),对照组给予生理盐水。停药后第2天处死裸鼠,剥离瘤结节,网搓法制备单细胞悬液。采用流式细胞术检测皮下种植瘤细胞凋亡率,细胞ABCG2蛋白表达及细胞内ADM含量。结果成功建立Eca109/ABCG2种植瘤裸鼠模型,1周内成瘤率为100%。与对照组比较,ADM+Art高、低剂量组皮下种植瘤细胞凋亡率显著增加(P<0.05),细胞中ABCG2蛋白表达量显著降低(P<0.05),ADM含量显著增加(P<0.05)。结论 ABCG2参与了食管癌多药耐药的形成,Art可通过降低食管癌细胞中ABCG2的表达从而逆转食管癌耐药作用。 Objective To explore the relationship between ABCG2 and multidrug resistance of esophageal cancer and the mechanism of resistance-reversal effect by artesunate(Art).Methods To establish the bearing cancer nude mice model by inoculating with Eca109/ABCG2 cells subcutaneously on the left subscapularis and study the resistance-reversal effect of artesunate on esophageal cancer using nude mice model.Injection drugs after subcutaneous tumor formation.Intraperitoneal injection with artesunate and adriamycin(ADM).To set up Art high and low dose group(50,25mg/kg Art),ADM group(1mg/kg ADM),ADM+ Art high and low dose group(1mg/kg ADM+50,25mg/kg Art) and control group in the saline.The second day of the withdrawal of drugs,the nude mice were euthanized by breaking neck.The nodules of mice were stripped,then making into single cell suspension fluid with nets rub method.The apoptosis rate,ABCG2 protein expression level and ADM content in transplanted tumor cells were detected by flow cytometry.Results The model of esophageal cancer cell Eca109/ABCG2 xenograft in nude mice was successfully established,the tumorigenic rate was 100%.The growth inhibitory effect,ADM content in tumor cells and the apoptosis rate of esophageal cancer xenograft tumor cells treated with ADM in vivo were enhanced by combining artesunate without causing obvious side effects in treated mice.The ABCG2 protein expression level was significantly decreased in ADM+ Art high and low dose group compared with ADM group(P0.05).Conclusion ABCG2 participated in the development of esophageal cancer multidrug-resistance,artesunate could reverse the resistance of esophageal cancer by reducing the expression level of ABCG2.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2011年第12期1301-1303,共3页 Medical Journal of Chinese People's Liberation Army
基金 河北省自然科学基金(C2007001060) 河北省普通高等学校强势特色学科肿瘤学建设经费资助(冀教高[2005]52号) 河北省医学科学研究重点课题(20110131)
关键词 青蒿素类 三磷酸腺苷结合转运蛋白G超家族成员2 基因 MDR 小鼠 artemisinins ATP-binding cassettes transporter G2(ABCG2) genes MDR mice nude
  • 相关文献

参考文献15

  • 1Rulisa S, Gatarayiha JP, Kaharvsa T, et al. Camparison of different artemisinin-based combinations for the treatment of Plaslmodium fal ciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrime thamine versus artesunate plus sulfamethoxypyrazine/pyrimethamine [J]. AmJ Trop Med Hyg, 2007, 77(4): 612-616.
  • 2Efferth T, Dunstan H, Sanerbrey A, et al. The anti malarial aresu nate is also active against cancer[J]. Int J Oncol, 2001, 18(4): 767- 773.
  • 3Efferth T, Briehl MM, Tome ME. Role of antioxidant genes for the activity of artesunate against tumor cells[J]. Int J Oncol, 2003, 23 (4) : 1231-1235.
  • 4刘亮,王静,郭建文,刘江惠,左连富.青蒿琥酯对人食管癌细胞的抑制作用及其可能的机制[J].中国肿瘤生物治疗杂志,2008,15(3):278-283. 被引量:8
  • 5刘亮,王静,刘江惠,郭建文,左连富.青蒿琥酯抗食管鳞癌作用机制的研究[J].中国医科大学学报,2008,37(4):529-531. 被引量:4
  • 6刘亮,赵丽,郭建文,刘江惠,王静,左连富.青蒿琥酯与阿霉素联用对人食管癌细胞生长及凋亡的影响[J].中国医科大学学报,2009,38(4):256-258. 被引量:3
  • 7刘亮,左静,赵丽,王静,郭建文,刘江惠,左连富.ABCG2食管癌耐药细胞系Eca109/ABCG2的建立[J].解放军医学杂志,2010,35(1):32-35. 被引量:8
  • 8Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters[J]. Nat Rev Cancer, 2002, 2 (1) : 18-58.
  • 9Fojo T, Coley HiVE The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies[J]. Clin Breast Cancer, 2007, 7(10) : 749 -756.
  • 10Gottesman MM, Ambudkar SV, Xia D. Structure of a muhidrug transporter[J]. Nat Biotechnol, 2009, 27(6) : 546-547.

二级参考文献51

  • 1李哲,袁守军,聂丽平,田增月,徐兰平,韩昌明.青蒿琥酯诱导肿瘤细胞凋亡与抑制存活蛋白表达有关[J].中国临床药理学与治疗学,2004,9(6):607-611. 被引量:41
  • 2赵君宁,何一然,张振玉,孙士其,王书奎.青蒿琥酯对人胃癌细胞增殖及凋亡的影响[J].中国癌症杂志,2005,15(4):347-350. 被引量:14
  • 3Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: rote of ATP-dependent transporters[J]. Nat Rev Cancer, 2002, 2 (1): 48-52.
  • 4Ceckova M, Libra A, Pavek P, et al. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo[J]. Clin Exp Pharmacol Physiol, 2006, 33(1-2): 58-63.
  • 5Nieolle E, Boccard J, Guilet D, et al. Breast cancer resistance protein (13CRP/ABCG2) :new inhibitors and QSAR studies by a 3D linear solvation energy approach[J]. Eur J Pharm Sci, 2009, 38(1): 39-45.
  • 6Mahringer A, Belzer J, Fricker G. A fluorescence-based in vitro assay for drug interactions with breast cancer resistance protein (BCRP, ABCG2)[J]. Eur J Pharm Biopharm, 2009, 72(3):605-610.
  • 7Larbcharoensub N, Leopairat J, Sirachainan E, et al. A.ssociation between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent ehemotherapy[J]. Hum Pathol, 2008, 39(6) : 837-841.
  • 8Tsuruo T. Molecular cancer therapeutics: recent progress and targets in drug resistance[J]. Intern Med, 2003, 42(3):237-243.
  • 9Ozvegy C, Varadi A, Sarkadi B, Characterization of drug transport ATP hydrolysis, and nucleotide trapping by the human ABCG2 mul tidrug transporter. Modulation of substrate specificity by a point rnu tation[J]. J Biol Chem, 2002, 277(50): 47980-47984.
  • 10Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) [J]. Oncogene, 2003, 22 (47): 7340- 7345.

共引文献22

同被引文献48

  • 1Liu J, Kouzine F, Nie Z, et al. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression[J]. EMBOJ, 2006, 25(10):2119-2130.
  • 2Chung H J, Levens D. c-myc E x pression: Keep the noise down[J]. Mol Cells, 2005, 20(2): 157-166.
  • 3Hersznyi L, Pregun I, Tulassay Z. Diagnosis and recognition of early esophageal neoplasia[ J]. Dig Dis, 2009, 27( 1): 24-30.
  • 4Zubaidah RM, Tan GS, Tan SBE, et al. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis[J]. Proteomics, 2008, 8(23-24): 5086-5096.
  • 5Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, et al. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth[J]. Hepatology, 2009, 50(4): 1121-1129.
  • 6Michael T, Peter B, Marie-luise H, et al. Use of the far upstream element (FUSE) binding protein (FUBP) as a marker for colorectal cancer: 2005015225[P]. 2005-02-17.
  • 7Engidawork E, Sadst L A, Yang JW, et al. Protein chemical identification and characterization of the human variants of far upstream element binding protein in medulloblastoma DAOY cell line[J]. Int J Oncol, 2006, 29(3): 721-736.
  • 8Weber A, Kristiansen I, Johannsen M, et al. The FUSE binding proteins FBP1 and FBP3 are potentialc-myc regulators in renal, but not in prostate and bladder cancer[J]. BMC Cancer, 2008, 8(369):1-11.
  • 9张祖贻,余世庆,苗立云,黄晓英,张晓萍,朱玉萍,夏小红,李丹奇.青蒿琥酯联合NP方案治疗中晚期非小细胞肺癌的随机对照研究[J].中西医结合学报,2008,6(2):134-138. 被引量:25
  • 10黄晓飞,袁丁,张长城,张小鹏.青蒿琥酯诱导人前列腺癌PC-3细胞分化及周期阻滞[J].中西医结合学报,2008,6(6):591-594. 被引量:6

引证文献3

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部